Literature DB >> 6573317

Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers.

J Guibert, M D Kitzis, C Yvelin, J F Acar.   

Abstract

The pharmacokinetic parameters of cefotetan were determined in six healthy adults after intramuscular (im) and intravenous (iv) administration of a single dose. After an iv bolus injection of 1 g cefotetan the mean peak serum level was 179.6 mg/l (S.E.M. +/- 14.2 mg/l) at 2 min. The apparent volume of distribution was 10.29 l (S.E.M. +/- 0.66 l). After im injections of 500 mg and 1 g of cefotetan the mean peak levels were 35 mg/l (S.E.M. +/- 1.6 mg/l) and 74 mg/l (S.E.M. +/- 3.6 mg/l) at 82 and 97 min respectively; the level at 12 h was 4.5 mg/l after 500 mg and 10.4 mg/l after 1 g. Cefotetan was slowly eliminated. The serum half-life was about 3.1 h after 1 g iv injection and varied from 3.4 to 3.7 h after the 500 mg and 1 g im injections. About 75% of the dose was excreted in the urine during the first 24 h after 1 g iv bolus injection; after 500 mg and 1 g im injection 60 to 65% of the dose was recovered in the urine during the same time period.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6573317     DOI: 10.1093/jac/11.suppl_a.201

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.

Authors:  J A Bosso; R A Prince
Journal:  Tex Heart Inst J       Date:  1990

2.  Pharmacokinetic differences between the epimers of cefotetan disodium after single intravenous injection in healthy Chinese volunteers.

Authors:  Meng-xiang Su; Min-hong Liu; Bin Di; Li-li Huang; Yuan Jiang; Peng-cheng Ma; Tai-jun Hang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-09-14       Impact factor: 2.441

Review 3.  Interethnic differences in pharmacokinetics of antibacterials.

Authors:  Danny Tsai; Janattul-Ain Jamal; Joshua S Davis; Jeffrey Lipman; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

4.  Forecasting cephalosporin and monobactam antibiotic half-lives in humans from data collected in laboratory animals.

Authors:  J Mordenti
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

5.  Penetration of cefotetan into suction skin blister fluid and tissue homogenates in patients undergoing abdominal surgery.

Authors:  T Mazzei; F Tonelli; A Novelli; F Ficari; C Mazzoni; A Anastasi; P Periti
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

6.  Determination of susceptibility of anaerobic bacteria to cefotetan and cefoxitin by the thioglycolate disk elution method.

Authors:  A L Barry; R R Packer
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

7.  A simple and sensitive liquid chromatographic technique for the determination of cefotetan disodium in human plasma and its application in a pharmacokinetic study.

Authors:  Yani Liu; Jiangeng Huang; Jinmei Liu; Lin Ma; Yongning Lv; Shaojun Shi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

Review 8.  Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Ward; D M Richards
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

9.  In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria.

Authors:  H M Wexler; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

10.  Cefotetan pharmacokinetics in volunteers with various degrees of renal function.

Authors:  B R Smith; J L LeFrock; P T Thyrum; B A Doret; C Yeh; G Onesti; A Schwartz; J J Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.